Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

ClinicalTrials.gov ID: NCT06948435

Public ClinicalTrials.gov record NCT06948435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 4:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.

Study identification

NCT ID
NCT06948435
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
487 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 29, 2025
Primary completion
Aug 31, 2027
Completion
Aug 31, 2027
Last update posted
May 28, 2026

2025 – 2027

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Elite Clinical Studies, LLC Phoenix Arizona 85018
Valley Clinical Trials, Inc. Covina California 91723
Valley Clinical Trials, Inc. Northridge California 91325
Chase Medical Research, LLC Waterbury Connecticut 06708
Excel Medical Clinical Trials Boca Raton Florida 33434
Care Access - Brandon Brandon Florida 33510
Northeast Research Institute - Downtown Office Jacksonville Florida 32204
Peace River Cardiovascular Center Port Charlotte Florida 33952
East-West Medical Research Institute Honolulu Hawaii 96814
Ascension Saint Agnes Heart Care Baltimore Maryland 21229
Lucida Clinical Trials New Bedford Massachusetts 02740
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division Troy Michigan 48098
StudyMetrix Research City of Saint Peters Missouri 63303
Excel Clinical Research, LLC Las Vegas Nevada 89109
Palm Research Center Sunset Las Vegas Nevada 89148
Rochester Clinical Research, LLC Rochester New York 14609
Remington-Davis, Inc Columbus Ohio 43215
PriMED Clinical Research Dayton Ohio 45429
Advanced Research Institute - Tigard Tigard Oregon 97223
Care Access - Mauldin Mauldin South Carolina 29662
Dallas Heart and Vascular Consultants, PA Duncanville Texas 75137
Texas Institute of Cardiology, PA McKinney Texas 75071
North Hills Family Medicine/North Hills Medical Research North Richland Hills Texas 76180
Advanced Research Institute Ogden Utah 84405
Carient Heart & Vascular - Manassas Manassas Virginia 20109
Health Research of Hampton Roads, Inc. Newport News Virginia 23606
National Clinical Research, Inc Richmond Virginia 23294
Eastside Research Associates Redmond Washington 98052

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06948435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2026 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06948435 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →